PROTEIN (TETANUS TOXIN HC)
Clostridium tetani
State in the Current Structure
| Assembly | Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Associated Components | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|
| 1 | Protein monomer Monomer Protein × 1 PDB declaration: monomeric(1) Consistent with protein copy count | Chain A; UniProt 872–1315 | Fragment:C-TERMINAL DOMAIN OF HEAVY CHAIN Mutation:ADDITION OF THE SEQUENCE MGHGHHHHHHHHHHSSGHIEGRHML AT THE N-TERMINAL RESIDUE 872 | A2G 2-acetamido-2-deoxy-alpha-D-galactopyranose × 2 SO4 SULFATE ION × 1 | X-RAY DIFFRACTION X-ray crystallization conditions:pH 7;pH 7.00 | Resolution 2.10 Å R-free 0.270 |
Other States of the Same Protein in the Database
Each row is a biological assembly of the same UniProt protein in another PDB entry. The “Difference from current entry” column identifies evidence-level differences; no tag means the currently parsed fields agree.
| Other PDB | Difference from Current Entry 1D0H | Assembly / Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Non-polymers | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|---|
| 1A8D TETANUS TOXIN C FRAGMENT Deposited 1998-03-23 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
864–1314(451 aa)
Fragment:C-FRAGMENT
|
Mutation:INS(M1) | AU GOLD ION × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
fiber seeding using cryshed initial crystals as seeds;pH 7;9% (W/V) 1M AMMONIUM PHOSPHATE, PH 6.0, AND 92% OF A 10% (W/V) SOLUTION OF PEG 6000 IN 50MM HEPES (PH 7.0). LARGE CRYSTALS (0.2 X 0.2 X 0.5 MM) WERE GROWN BY FIBER SEEDING, USING CRUSHED INITIAL CRYSTALS AS SEEDS., fiber seeding using cryshed initial crystals as seeds
|
Resolution 1.57 Å R-free 0.262 |
| 1AF9 TETANUS NEUROTOXIN C FRAGMENT Deposited 1997-03-24 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
864–1314(451 aa)
Fragment:C FRAGMENT
|
Mutation:MET INSERTED AT N-TERMINUS | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.5;CRYSTALLIZATION DROP CONTAINED 3 PARTS RESERVOIR SOLUTION AND 1 PART PROTEIN SOLUTION. RESERVOIR: 14%- 18% PEG 4000, 0.1M IMIDAZOLE, 0.05M MGCL2 AT PH 6.5. PROTEIN SOLUTION: 10MG/ML PROTEIN AND 0.01M TRIS-HCL AT PH 7.8.
|
Resolution 2.70 Å R-free 0.245 |
| 1DFQ THE HC FRAGMENT OF TETANUS TOXIN COMPLEXED WITH SIALIC ACID Deposited 1999-11-20 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
871–1314(444 aa)
Fragment:C-TERMINAL DOMAIN OF HEAVY CHAIN
|
Not recorded | SLB N-acetyl-beta-neuraminic acid × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;295 K;IMIDAZOLE, SODIUM CHLORIDE, AMMONIUM SULFATE, PEG4000, 2-METHYL-2,4-PENTANE-DIOL, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 295K
|
Resolution 2.60 Å R-free 0.313 |
| 1DIW THE HC FRAGMENT OF TETANUS TOXIN COMPLEXED WITH GALACTOSE Deposited 1999-11-30 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
874–1314(441 aa)
|
Not recorded | GAL beta-D-galactopyranose × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;295 K;IMIDAZOLE, SODIUM CHLORIDE, AMMONIUM SULPHATE, PEG4000, 2-METHYL-2,4-PENTANE-
DIOL, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 295K
|
Resolution 2.00 Å R-free 0.267 |
| 1DLL The HC fragement of tetanus toxin complexed with lactose Deposited 1999-12-10 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
874–1314(441 aa)
Fragment:RECEPTOR BINDING FRAGMENT HC
|
Not recorded | GOL GLYCEROL × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;295 K;imidazole, sodium chloride, ammonium sulphate, PEG4000, 2-methyl-2,4-pentane-diol, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 295K
|
Resolution 1.80 Å R-free 0.267 |
| 1FV2 The Hc fragment of tetanus toxin complexed with an analogue of its ganglioside receptor GT1B Deposited 2000-09-18 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
864–1314(451 aa)
Fragment:C-TERMINAL DOMAIN OF HEAVY CHAIN
|
Not recorded | PO4 PHOSPHATE ION × 1 CEQ ETHYL-TRIMETHYL-SILANE × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;293 K;20% Polyethylene glycol 8000, sodium-potassium phosphate, TRIS, imidazole, sodium chloride, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K
|
Resolution 2.50 Å R-free 0.276 |
| 1FV3 THE HC FRAGMENT OF TETANUS TOXIN COMPLEXED WITH AN ANALOGUE OF ITS GANGLIOSIDE RECEPTOR GT1B Deposited 2000-09-18 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
864–1314(451 aa)
Fragment:C-TERMINAL DOMAIN OF HEAVY CHAIN
|
Not recorded | CEQ ETHYL-TRIMETHYL-SILANE × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8.5;293 K;20% Polyethylene glycol 8000, sodium-potassium phosphate, TRIS, imidazole, sodium chloride, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K
|
Resolution 2.30 Å R-free 0.306 |
| 1FV3 THE HC FRAGMENT OF TETANUS TOXIN COMPLEXED WITH AN ANALOGUE OF ITS GANGLIOSIDE RECEPTOR GT1B Deposited 2000-09-18 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Other combination Monomer;Protein × 1 PDB declaration: monomeric |
Chain B
864–1314(451 aa)
Fragment:C-TERMINAL DOMAIN OF HEAVY CHAIN
|
Not recorded | CEQ ETHYL-TRIMETHYL-SILANE × 1 PO4 PHOSPHATE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8.5;293 K;20% Polyethylene glycol 8000, sodium-potassium phosphate, TRIS, imidazole, sodium chloride, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K
|
Resolution 2.30 Å R-free 0.306 |
| 1YVG Structural analysis of the catalytic domain of tetanus neurotoxin Deposited 2005-02-15 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
1–457(457 aa)
Fragment:chain L
|
Not recorded | ZN ZINC ION × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.2;293 K;PEG 4000, magnesium chloride, hepes buffer, pH 7.2, VAPOR DIFFUSION, SITTING DROP, temperature 293K
|
Resolution 2.60 Å R-free 0.276 |
| 1YVG Structural analysis of the catalytic domain of tetanus neurotoxin Deposited 2005-02-15 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
1–457(457 aa)
Fragment:chain L
|
Not recorded | ZN ZINC ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.2;293 K;PEG 4000, magnesium chloride, hepes buffer, pH 7.2, VAPOR DIFFUSION, SITTING DROP, temperature 293K
|
Resolution 2.60 Å R-free 0.276 |
| 1YXW A common binding site for disialyllactose and a tri-peptide in the C-fragment of tetanus neurotoxin Deposited 2005-02-22 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
874–1314(441 aa)
|
Not recorded | TYR TYROSINE × 1 GLU GLUTAMIC ACID × 1 TRP TRYPTOPHAN × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;PEG 4000, imidazol, MgCl2, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K
|
Resolution 2.20 Å R-free 0.274 |
| 1YYN A common binding site for disialyllactose and a tri-peptide in the C-fragment of tetanus neurotoxin Deposited 2005-02-25 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
874–1314(441 aa)
Fragment:residues 875-1315
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;PEG 4000, imidazol, MgCl2, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K
|
Resolution 2.30 Å R-free 0.288 |
| 1Z7H 2.3 Angstrom crystal structure of tetanus neurotoxin light chain Deposited 2005-03-24 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
0–442(443 aa)
|
Mutation:I361V | ZN ZINC ION × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.4;293 K;PEG 3350, MAGNESIUM NITRATE, pH 7.4, VAPOR DIFFUSION, HANGING DROP, temperature 20K
|
Resolution 2.30 Å R-free 0.216 |
| 3HMY Crystal structure of HCR/T complexed with GT2 Deposited 2009-05-29 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
866–1315(450 aa)
Fragment:Receptor binding domain (UNP residues 866-1315)
|
Not recorded | GOL GLYCEROL × 1 SO4 SULFATE ION × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;292 K;Bis-Tis propane buffer pH 7.0, 25% PEG2K and 300 mM Ammonium sulfate, VAPOR DIFFUSION, HANGING DROP, temperature 292K
|
Resolution 2.00 Å R-free 0.237 |
| 3HN1 Crystal structure of HCR/T complexed with GT2 and lactose Deposited 2009-05-29 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
866–1315(450 aa)
Fragment:Receptor binding domain (UNP residues 866-1315)
|
Not recorded | GLA alpha-D-galactopyranose × 1 SO4 SULFATE ION × 3 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;292 K;Bis-Tris propane, PEG2K and ammonium sulfate, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 292K
|
Resolution 2.10 Å R-free 0.257 |
| 4J1L Mutant Endotoxin TeNT Deposited 2013-02-01 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
2–427(426 aa)
Fragment:UNP residues 2-427
|
Mutation:K168E, L230I | ZN ZINC ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;293 K;pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 2.60 Å R-free 0.266 |
| 5N0B Crystal structure of the tetanus neurotoxin in complex with GD1a Deposited 2017-02-02 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
1–1315(1315 aa)
|
Mutation:R372A, Y375F | ZN ZINC ION × 1 PEG DI(HYDROXYETHYL)ETHER × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;20% v/v polyethylene glycol 3350, 0.1M Bis-Tris propane pH 6.5, 0.2M potassium thiocyanate
|
Resolution 2.60 Å R-free 0.247 |
| 5N0C Crystal structure of the tetanus neurotoxin in complex with GM1a Deposited 2017-02-02 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
1–1315(1315 aa)
|
Mutation:R372A, Y375F | ZN ZINC ION × 1 PEG DI(HYDROXYETHYL)ETHER × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6;293 K;20% v/v polyethylene glycol 6000, 0.1M MES pH 6.0, 0.2M sodium chloride
|
Resolution 2.60 Å R-free 0.253 |
| 5N0C Crystal structure of the tetanus neurotoxin in complex with GM1a Deposited 2017-02-02 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Other combination Monomer;Protein × 1 PDB declaration: monomeric |
Chain B
1–1315(1315 aa)
|
Mutation:R372A, Y375F | ZN ZINC ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6;293 K;20% v/v polyethylene glycol 6000, 0.1M MES pH 6.0, 0.2M sodium chloride
|
Resolution 2.60 Å R-free 0.253 |
| 7BXX Tetanus neurotoxin translocation domain -C467S Deposited 2020-04-21 | Different construct Different mutation/modification Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
459–864(406 aa)
|
Mutation:C467S | No recorded non-water small molecule |
Experimental method not declared
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.6;293 K;0.225M MES/Bis-Tris pH 6.6, 6.6% PEG6000
|
Resolution 2.34 Å R-free 0.253 |
| 7BXX Tetanus neurotoxin translocation domain -C467S Deposited 2020-04-21 | Different construct Different mutation/modification Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain B
459–864(406 aa)
|
Mutation:C467S | No recorded non-water small molecule |
Experimental method not declared
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.6;293 K;0.225M MES/Bis-Tris pH 6.6, 6.6% PEG6000
|
Resolution 2.34 Å R-free 0.253 |
| 7BY4 Tetanus neurotoxin receptor binding domain Deposited 2020-04-21 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
865–1315(451 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF) | BTB 2-[BIS-(2-HYDROXY-ETHYL)-AMINO]-2-HYDROXYMETHYL-PROPANE-1,3-DIOL × 1 NA SODIUM ION × 1 GOL GLYCEROL × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;0.1 M Bis-Tris pH 6.0, 0.1 M Pottasium chloride 22.5% PEG 4000
|
Resolution 1.50 Å R-free 0.163 |
| 7BY5 Tetanus neurotoxin mutant-(H233A/E234Q/H237A/Y375F) Deposited 2020-04-21 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
2–1315(1314 aa)
|
Mutation:H233A,E234Q,H237A,Y375F | EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 1 EDO 1,2-ETHANEDIOL × 8 NA SODIUM ION × 3 CL CHLORIDE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;293 K;0.1 M MOPS pH 7.0, 9% PEG 8000
|
Resolution 2.27 Å R-free 0.233 |
| 9FYQ Cryo-EM structure of native SV2A in complex with TeNT-Hc, gangliosides and Pro-Macrobody 5 Deposited 2024-07-03 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Heteromer;Protein × 3 PDB declaration: trimeric |
Chain C
875–1315(441 aa)
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 6UZ omega-undecylenyl-beta-D-maltopyranoside × 1 A1IHM (2~{R},4~{R},5~{S},6~{S})-2-[(2~{R},3~{R})-3-[(2~{R},3~{S},4~{S},6~{S})-6-[(2~{S},3~{S},4~{R},5~{S},6~{S})-3-[(2~{R},3~{R},4~{R},5~{S},6~{R})-3-acetamido-6-(hydroxymethyl)-4,5-bis(oxidanyl)oxan-2-yl]oxy-2-(hydroxymethyl)-6-[(2~{R},3~{R},4~{R},5~{R},6~{S})-2-(hydroxymethyl)-6-[2-(octadecanoylamino)-3-oxidanyl-octadec-4-enoxy]-4,5-bis(oxidanyl)oxan-3-yl]oxy-5-oxidanyl-oxan-4-yl]oxy-3-azanyl-6-carboxy-4-oxidanyl-oxan-2-yl]-2,3-bis(oxidanyl)propoxy]-5-azanyl-4-oxidanyl-6-[(1~{R},2~{S})-1,2,3-tris(oxidanyl)propyl]oxane-2-carboxylic acid × 1 A1IHN (2~{S},4~{S},5~{R},6~{S})-5-acetamido-2-[(2~{R},3~{R},4~{R},5~{S},6~{R})-2-[(2~{R},3~{R},4~{S},5~{R},6~{S})-2-[(2~{R},3~{S},4~{R},5~{R},6~{R})-4-[(2~{S},4~{S},5~{S},6~{S})-5-acetamido-2-carboxy-4-oxidanyl-6-[(1~{S},2~{R})-1,2,3-tris(oxidanyl)propyl]oxan-2-yl]oxy-6-[(2~{R},3~{S},4~{R},5~{R},6~{R})-6-[2-(docosanoylamino)-3-oxidanyl-octadec-4-enoxy]-2-(hydroxymethyl)-4,5-bis(oxidanyl)oxan-3-yl]oxy-2-(hydroxymethyl)-5-oxidanyl-oxan-3-yl]oxy-6-(hydroxymethyl)-5-oxidanyl-3-(2-oxidanylidenepropyl)oxan-4-yl]oxy-6-(hydroxymethyl)-3,5-bis(oxidanyl)oxan-4-yl]oxy-4-oxidanyl-6-[(1~{R},2~{R})-1,2,3-tris(oxidanyl)propyl]oxane-2-carboxylic acid × 1 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5;10 mM Hepes-NaOH 7.5, 150 mM NaCl, 3 mM maltose, 0.03 % n-dodecyl-beta-D-maltopyranoside, 0.006% cholesterol hemisuccinate
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.25 Å |
| 9FYR Cryo-EM structure of native SV2A in complex with TeNT-Hc, Pro-Macrobody 5 and Levetiracetam Deposited 2024-07-03 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Heteromer;Protein × 3 PDB declaration: trimeric |
Chain C
875–1315(441 aa)
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 6UZ omega-undecylenyl-beta-D-maltopyranoside × 1 UKX (2S)-2-(2-oxidanylidenepyrrolidin-1-yl)butanamide × 1 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5;10 mM Hepes-NaOH 7.5, 150 mM NaCl, 3 mM maltose, 0.03 % n-dodecyl-beta-D-maltopyranoside, 0.006% cholesterol hemisuccinate, 250 uM Levetiracetam
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.60 Å |
21 other PDB entries and 25 assemblies. Open the comparison page and filter oligomeric states
View Construct and Data Evidence
| UniProt name | TETX_CLOTE |
| Isoform | — |
| PDB entities | 1 |
| Chains and sequence ranges | Author chain A; PDBConstruct 26–469; UniProt 872–1315 |